Get Premium to unlock powerful stock data

ACT Capital, L.L.C. Buys INmune Bio Inc, IDEAYA Biosciences Inc, Affirm Holdings Inc, Sells Cassava Sciences Inc, Unity Software Inc, The Beauty Health Co

Author's Avatar
insider
Nov 17, 2021
Article's Main Image
Investment company ACT Capital, L.L.C. (Current Portfolio) buys INmune Bio Inc, IDEAYA Biosciences Inc, Affirm Holdings Inc, GoodRx Holdings Inc, Chevron Corp, sells Cassava Sciences Inc, Unity Software Inc, The Beauty Health Co, F5 Inc, Novavax Inc during the 3-months ended 2021Q3, according to the most recent filings of the investment company, ACT Capital, L.L.C.. As of 2021Q3, ACT Capital, L.L.C. owns 107 stocks with a total value of $190 million. These are the details of the buys and sells.

For the details of ACT Capital, L.L.C.'s stock buys and sells, go to https://www.gurufocus.com/guru/act+capital%2C+l.l.c./current-portfolio/portfolio

These are the top 5 holdings of ACT Capital, L.L.C.
  1. Staar Surgical Co (STAA) - 268,200 shares, 18.12% of the total portfolio. Shares added by 15.80%
  2. Arcturus Therapeutics Holdings Inc (ARCT) - 455,300 shares, 11.44% of the total portfolio.
  3. Clearside Biomedical Inc (CLSD) - 2,467,500 shares, 7.78% of the total portfolio. Shares added by 0.20%
  4. Arrowhead Pharmaceuticals Inc (ARWR) - 194,000 shares, 6.37% of the total portfolio. Shares reduced by 7%
  5. Trillium Therapeutics Inc (TRIL) - 466,000 shares, 4.30% of the total portfolio. Shares added by 0.22%
New Purchase: INmune Bio Inc (INMB)

ACT Capital, L.L.C. initiated holding in INmune Bio Inc. The purchase prices were between $14.13 and $27.85, with an estimated average price of $19.39. The stock is now traded at around $13.580000. The impact to a portfolio due to this purchase was 2.81%. The holding were 275,000 shares as of 2021-09-30.

New Purchase: GoodRx Holdings Inc (GDRX)

ACT Capital, L.L.C. initiated holding in GoodRx Holdings Inc. The purchase prices were between $29.63 and $46.98, with an estimated average price of $36.33. The stock is now traded at around $41.600000. The impact to a portfolio due to this purchase was 0.86%. The holding were 40,000 shares as of 2021-09-30.

New Purchase: Chevron Corp (CVX)

ACT Capital, L.L.C. initiated holding in Chevron Corp. The purchase prices were between $94.29 and $106.21, with an estimated average price of $99.81. The stock is now traded at around $115.910000. The impact to a portfolio due to this purchase was 0.85%. The holding were 16,000 shares as of 2021-09-30.

New Purchase: Matterport Inc (MTTR)

ACT Capital, L.L.C. initiated holding in Matterport Inc. The purchase prices were between $13.41 and $23.23, with an estimated average price of $16.81. The stock is now traded at around $29.280000. The impact to a portfolio due to this purchase was 0.82%. The holding were 82,500 shares as of 2021-09-30.

New Purchase: Anavex Life Sciences Corp (AVXL)

ACT Capital, L.L.C. initiated holding in Anavex Life Sciences Corp. The purchase prices were between $16.82 and $25.75, with an estimated average price of $19.97. The stock is now traded at around $21.290100. The impact to a portfolio due to this purchase was 0.66%. The holding were 70,500 shares as of 2021-09-30.

New Purchase: Katapult Holdings Inc (KPLT)

ACT Capital, L.L.C. initiated holding in Katapult Holdings Inc. The purchase prices were between $3.18 and $11.45, with an estimated average price of $7.02. The stock is now traded at around $4.488500. The impact to a portfolio due to this purchase was 0.5%. The holding were 175,000 shares as of 2021-09-30.

Added: IDEAYA Biosciences Inc (IDYA)

ACT Capital, L.L.C. added to a holding in IDEAYA Biosciences Inc by 150.72%. The purchase prices were between $17.26 and $27.08, with an estimated average price of $23.35. The stock is now traded at around $23.470000. The impact to a portfolio due to this purchase was 1.4%. The holding were 173,500 shares as of 2021-09-30.

Added: Affirm Holdings Inc (AFRM)

ACT Capital, L.L.C. added to a holding in Affirm Holdings Inc by 390.00%. The purchase prices were between $55.86 and $128.37, with an estimated average price of $79.94. The stock is now traded at around $156.372000. The impact to a portfolio due to this purchase was 1.22%. The holding were 24,500 shares as of 2021-09-30.

Added: Krystal Biotech Inc (KRYS)

ACT Capital, L.L.C. added to a holding in Krystal Biotech Inc by 109.70%. The purchase prices were between $52.01 and $71.77, with an estimated average price of $59.35. The stock is now traded at around $49.530000. The impact to a portfolio due to this purchase was 0.58%. The holding were 40,000 shares as of 2021-09-30.

Added: Amazon.com Inc (AMZN)

ACT Capital, L.L.C. added to a holding in Amazon.com Inc by 150.00%. The purchase prices were between $3187.75 and $3731.41, with an estimated average price of $3451.22. The stock is now traded at around $3553.405000. The impact to a portfolio due to this purchase was 0.52%. The holding were 500 shares as of 2021-09-30.

Added: Cyteir Therapeutics Inc (CYT)

ACT Capital, L.L.C. added to a holding in Cyteir Therapeutics Inc by 16566.67%. The purchase prices were between $14.57 and $21.86, with an estimated average price of $18.73. The stock is now traded at around $16.500000. The impact to a portfolio due to this purchase was 0.14%. The holding were 15,000 shares as of 2021-09-30.

Added: PDS Biotechnology Corp (PDSB)

ACT Capital, L.L.C. added to a holding in PDS Biotechnology Corp by 33.33%. The purchase prices were between $9.33 and $17.08, with an estimated average price of $12.5. The stock is now traded at around $10.360000. The impact to a portfolio due to this purchase was 0.12%. The holding were 60,000 shares as of 2021-09-30.

Sold Out: Cassava Sciences Inc (SAVA)

ACT Capital, L.L.C. sold out a holding in Cassava Sciences Inc. The sale prices were between $41.79 and $135.3, with an estimated average price of $83.05.

Sold Out: The Beauty Health Co (SKIN)

ACT Capital, L.L.C. sold out a holding in The Beauty Health Co. The sale prices were between $16.76 and $28.26, with an estimated average price of $22.02.

Sold Out: F5 Inc (FFIV)

ACT Capital, L.L.C. sold out a holding in F5 Inc. The sale prices were between $182.95 and $212.95, with an estimated average price of $199.83.

Sold Out: Novavax Inc (NVAX)

ACT Capital, L.L.C. sold out a holding in Novavax Inc. The sale prices were between $177.8 and $270.58, with an estimated average price of $220.82.

Sold Out: InMode Ltd (INMD)

ACT Capital, L.L.C. sold out a holding in InMode Ltd. The sale prices were between $45.58 and $88.24, with an estimated average price of $60.91.

Sold Out: Gores Holdings VI Inc (GHVI)

ACT Capital, L.L.C. sold out a holding in Gores Holdings VI Inc. The sale prices were between $13.25 and $15.98, with an estimated average price of $14.46.



Here is the complete portfolio of ACT Capital, L.L.C.. Also check out:

1. ACT Capital, L.L.C.'s Undervalued Stocks
2. ACT Capital, L.L.C.'s Top Growth Companies, and
3. ACT Capital, L.L.C.'s High Yield stocks
4. Stocks that ACT Capital, L.L.C. keeps buying
Rating:
NaN / 5 ( votes)
Author's Avatar
WRITTEN BY

GuruFocus Screeners

Related Articles

Q&A with Gurus